Marice Schwartz
Adult Health · Fresh Meadows, NYNPI 1730148800
Payments from drug & device makers
Across 147 payments — averaging $25.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$833
- Otsuka America Pharmaceutical, Inc.$454
- Ardelyx, Inc.$371
- Aurinia Pharma U.S., Inc.$338
- Takeda Pharmaceuticals U.S.A., Inc.$244
- Calliditas Therapeutics US Inc.$189
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,64298%
- Education$772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 35 | $833 |
| Otsuka America Pharmaceutical, Inc. | 22 | $454 |
| Ardelyx, Inc. | 16 | $371 |
| Aurinia Pharma U.S., Inc. | 17 | $338 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $244 |
| Calliditas Therapeutics US Inc. | 9 | $189 |
| AstraZeneca | 4 | $186 |
| Amgen | 7 | $164 |
| Akebia Therapeutics Inc | 6 | $141 |
| Travere Therapeutics, Inc. | 6 | $138 |
| Vantive US Healthcare LLC | 1 | $137 |
| Baxter Healthcare | 2 | $137 |
| Gilead | 1 | $125 |
| Fresenius USA Marketing, Inc. | 4 | $87 |
| OPKO Pharmaceuticals, LLC | 3 | $77 |
| Lilly USA, LLC | 1 | $31 |
| Bayer | 1 | $28 |
| Novartis | 1 | $22 |
| Fresenius USA Manufacturing, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Renal - PD$137
- LOKELMA$125
- Veklury$125
How this compares
$3,719 in reported general payments places this provider in the 85th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 30 | $100,939 |
| XphozahTenapanor Hcl | 21 | $58,611 |
| Sevelamer Carbonate | 122 | $18,073 |
| LokelmaSodium Zirconium Cyclosilicate | 18 | $13,632 |
| Lanthanum Carbonate | 14 | $8,856 |
| JanuviaSitagliptin Phosphate | 13 | $7,507 |
| Calcium Acetate | 27 | $3,018 |
| Bumetanide | 30 | $1,676 |
| Nifedipine ErNifedipine | 44 | $1,081 |
| Midodrine Hcl | 23 | $999 |
| Gentamicin Sulfate | 17 | $727 |
| Ammonium Lactate | 21 | $553 |
| Losartan Potassium | 36 | $221 |
| Pantoprazole Sodium | 46 | $206 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 13 | $174 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Fresenius USA Marketing, Inc.Velphoro | $87 | $100,93930 claims |
| AstraZenecaLokelma | $186 | $13,63218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,828 adult health providers in New York.
Other adult health in Fresh Meadows
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.